Browsing Tag
INSPIRE-1
1 post
Sun Pharmaceutical (SUNPHARMA) gains US approval for ILUMYA as Q2 profit falls 36%
Sun Pharmaceutical Industries has secured United States regulatory approval to expand ILUMYA into active psoriatic arthritis, strengthening its innovative medicines portfolio. The approval coincides with double-digit quarterly revenue growth but a sharp decline in reported profit, leaving product commercialisation and acquisition integration as important financial tests.
November 2, 2026